THIO Sequenced With Cemiplimab in Advanced NSCLC

Clinical trial NCT05208944 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05208944
Sponsor: Maia Biotechnology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2022-06-08
Primary completion: 2027-09-30
Enrollment: 227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.